Skip to content

Agilon Health AGL Liability for Claims and Claims Adjustment Expense

Liability for Claims and Claims Adjustment Expense at other companies

Elevance Health logo
Elevance HealthELV
$18.43B+9.6%
Astrana Health logo
Astrana HealthASTH
Alignment Healthcare logo
Alignment HealthcareALHC
Centene logo
CenteneCNC

Other financials

Income statement

See full
Revenue$1.4B-7.3%
Operating income$4.0M+118%
Net income$48.9M+304%
EPS (diluted)$2.94+303%

Balance sheet

See full
Cash & equivalents$211.6M+52.6%
Total debt$33.4M-20.5%
Total equity$181.4M-63.7%
Total assets$1.5B-22.1%

Cash flow

See full
Operating cash flow$23.7M+174%
CapEx$3.1M-19.4%
Free cash flow$20.6M+158%

Valuation

See full
Market cap$1.78B-92.6%
Enterprise value$1.61B-103%
P/S0.3×-3.8×

Profitability

See full
Operating margin-7.5%+6.5pp
Net margin-6.1%+6.3pp
FCF margin-1.1%

Returns & leverage

See full
Return on equity-104%-291pp
Debt / equity0.2×+0.1×
Current ratio-0.2×

Where this comes from

Reported directly by Agilon Health in its filing.

Tagged under the XBRL concept us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense.

The official record: Agilon Health’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Agilon Health's liability for claims and claims adjustment expense.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Agilon Health's liability for claims and claims adjustment expense?
Agilon Health (AGL) reported liability for claims and claims adjustment expense of $1.06B in Q1 2026.
How has Agilon Health's liability for claims and claims adjustment expense changed year-over-year?
Agilon Health's liability for claims and claims adjustment expense decreased by 5.2% year-over-year, from $1.11B to $1.06B.
What is the long-term trend for Agilon Health's liability for claims and claims adjustment expense?
Over 5 years (2020 to 2025), Agilon Health's liability for claims and claims adjustment expense has grown at a 41.7% compound annual growth rate (CAGR), from $162.87M to $929.77M.